ALS/Frontotemporal Dementia: Finding a Gene Biomarker for Both Diseases
In this video, our editors discuss a new study that suggests that transthyretin could serve as the first gene-specific biomarker for ALS and frontotemporal dementia. Dr. Brent Fogel discusses the findings with Neurology Today Editor-in-chief Dr. Steven Ringel and Associate Editor Dr. Robert Holloway Jr.
Neurology Today. 15(9):7, May 7, 2015